Disability worsens significantly faster after women with multiple sclerosis (MS) go through menopause, a new study shows.

Setting a specific, attainable New Year's resolution is key to following through, says columnist Leigh Anne Nelson, who ...

Patient enrollment is completed ahead of schedule for Contineum's Phase 2 clinical trial of PIPE-307, an oral remyelination ...

A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...

Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Columnist Ahna Crum is taking on a new year with a different approach: meeting the day-to-day new beginnings in life with ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

In the five years leading up to a multiple sclerosis (MS) diagnosis, children and adolescents often experience obesity and symptoms such as sensory disturbances and vision problems ...